BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25106875)

  • 1. PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins.
    Birnbaum Y; Nanhwan MK; Ling S; Perez-Polo JR; Ye Y; Bajaj M
    Cardiovasc Drugs Ther; 2014 Oct; 28(5):447-57. PubMed ID: 25106875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abrogating the induction of type 2 diabetes mellitus secondary to statin therapy.
    Planchon SM
    Cardiovasc Drugs Ther; 2014 Oct; 28(5):393-4. PubMed ID: 25178970
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
    Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
    Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.
    Ye Y; Qian J; Castillo AC; Ling S; Ye H; Perez-Polo JR; Bajaj M; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(1):H131-41. PubMed ID: 23103492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus.
    Birnbaum Y; Castillo AC; Qian J; Ling S; Ye H; Perez-Polo JR; Bajaj M; Ye Y
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):445-56. PubMed ID: 22936458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.
    Florentin M; Liberopoulos EN; Rizos CV; Kei AA; Liamis G; Kostapanos MS; Elisaf MS
    Metab Syndr Relat Disord; 2013 Jun; 11(3):152-6. PubMed ID: 23170931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose.
    Kostapanos MS; Milionis HJ; Agouridis AD; Rizos CV; Elisaf MS
    Int J Clin Pract; 2009 Sep; 63(9):1308-13. PubMed ID: 19691613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New analysis supports expanded use of statins in women.
    Harv Womens Health Watch; 2010 Apr; 17(8):6. PubMed ID: 20506603
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
    Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB
    Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.
    Moutzouri E; Liberopoulos E; Mikhailidis DP; Kostapanos MS; Kei AA; Milionis H; Elisaf M
    Int J Clin Pract; 2011 Nov; 65(11):1141-8. PubMed ID: 21995692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization.
    Naples M; Federico LM; Xu E; Nelken J; Adeli K
    Atherosclerosis; 2008 May; 198(1):94-103. PubMed ID: 18093597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.
    Guo H; Lv H; Tang W; Chi J; Liu L; Xu F; Ji Z; Zhai X; Peng F
    Cardiovasc Drugs Ther; 2012 Oct; 26(5):375-82. PubMed ID: 22918601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.
    Bellia A; Rizza S; Lombardo MF; Donadel G; Fabiano R; Andreadi K; Quon MJ; Sbraccia P; Federici M; Tesauro M; Cardillo C; Lauro D
    Atherosclerosis; 2012 Jul; 223(1):197-203. PubMed ID: 22658255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury.
    Schäfer K; Kaiser K; Konstantinides S
    Thromb Haemost; 2005 Jan; 93(1):145-52. PubMed ID: 15630505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
    Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW
    Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of rosuvastatin.
    Shepherd J; Hunninghake DB; Stein EA; Kastelein JJ; Harris S; Pears J; Hutchinson HG
    Am J Cardiol; 2004 Oct; 94(7):882-8. PubMed ID: 15464670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of HMG-CoA reductase inhibitor on insulin resistance in patients undergoing peritoneal dialysis.
    Doh FM; Chang TI; Koo HM; Lee MJ; Shin DH; Kim CH; Ko KI; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):501-9. PubMed ID: 22956052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
    Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
    Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful desensitization to rosuvastatin in a patient with a history of anaphylaxis to multiple statins.
    Khan FS; Stewart DK; Brunzell JD; Natrajan KM; Castells MC; Henderson WR; Ayars AG
    J Allergy Clin Immunol; 2013 Jan; 131(1):234-6. PubMed ID: 23177998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.